Rexahn Pharmaceuticals, Inc. (NYSE:RNN) shares are up more than 17.82% this year and recently increased 10.70% or $0.23 to settle at $2.38. LiqTech International, Inc. (NYSE:LIQT), on the other hand, is up 26.52% year to date as of 05/18/2018. It currently trades at $0.72 and has returned 53.28% during the past week. Rexahn Pharmaceuticals, Inc.
May 21 (Reuters) – Dova Pharmaceuticals Inc: * DOVA PHARMACEUTICALS ANNOUNCES U.S. FDA APPROVAL OF DOPTELET® (AVATROMBOPAG) * DOVA PHARMACEUTICALS INC – POSITIONED TO LAUNCH DOPTELET IN JUNE Source text for Eikon: Further company coverage: Our Standards:The Thomson Reuters Trust Principles. This article was originally posted elsewhere. Link to original article.
MAHWAH, N.J., May 21, 2018 /PRNewswire/ — Glenmark Pharmaceuticals, a global pharmaceutical company, today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food & Drug Administration (FDA) for its leading respiratory pipeline candidate Ryaltris™ (rye – al’ – tris), an investigational fixed-dose combination nasal spray of an antihistamine and
The Clorox Company (NYSE:CLX) recent drop took place on significantly more volume which surged nearly 2.29 million contracts on 18-May-18 versus its daily average of 1.25 million. The first sale was made at $117.98 but later the stock became weaker, and closed with a fall of -0.85%. It was last traded at $117.33 apiece. The
Company to Host Conference Call at 4:30 pm DURHAM, N.C., May 21, 2018 (GLOBE NEWSWIRE) — Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) today announced the U.S. Food and Drug Administration (FDA) has completed their Priority Review and approved DOPTELET® (avatrombopag) for the treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) who are scheduled to
Colgate-Palmolive Company (NYSE:CL) recently saw its volume around 5.03 million shares and on average it trades 4.23 million shares a day. The opening price of $62.32, led it to gain -0.11% to reach $62.22 upon the closing bell. Colgate-Palmolive Company (CL) Analyst Opinion Colgate-Palmolive Company has a consensus hold rating from 20 Wall Street analysts,
Last Thursday the FDA published a name-and-shame list of brand-name drug makers that may be withholding access to samples that competing drug makers could use to have generic versions available for use when the original manufacturer’s patent expires. Celgene (NASDAQ:CELG), Johnson & Johnson’s (NYSE:JNJ) Actelion unit, Novartis (NYSE:NVS) and Gilead Sciences (NASDAQ:GILD) top the list
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares are up more than 28.47% this year and recently increased 3.06% or $0.11 to settle at $3.70. Schneider National, Inc. (NYSE:SNDR), on the other hand, is up 2.94% year to date as of 05/18/2018. It currently trades at $29.40 and has returned 2.62% during the past week. Achillion Pharmaceuticals, Inc.